YPrime Survey Finds 62% of Clinical Site Staff Report eCOA Platforms are Misaligned with Site Needs
25 sept. 2024 09h00 HE
|
Y-Prime, LLC
YPrime releases report on site technology experiences, offering sponsors insights to improve trial efficiency by aligning eCOA platforms with user needs.
New YPrime Report Highlights eCOA's Impact on CNS Trials
01 mai 2024 08h00 HE
|
Y-Prime, LLC
YPrime has released a new report, Insights into CNS Clinical Trials, which demonstrates to sponsors how eCOA can help streamline CNS research.
YPrime Unveils a Transformative Brand Focused on Solving for Certainty in Clinical Trials
22 janv. 2024 07h45 HE
|
Y-Prime, LLC
YPrime announces bold rebranding and re-commitment to provide cutting-edge technologies to streamline and accelerate clinical trials.
Micron Announces New Semiconductor Assembly and Test Facility in India
22 juin 2023 07h00 HE
|
Micron Technology, Inc.
BOISE, Idaho, June 22, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ: MU), one of the world’s largest semiconductor companies, today announced plans to build a new assembly and test...
OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease
25 avr. 2023 02h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
Erold SA : Chiffre d’affaires du 1er semestre 2022
27 juil. 2022 11h45 HE
|
Erold SA
Chiffre d’affaires du 1er semestre 2022 Erold (FR0010211037 – ALPLA), groupe média numérique indépendant, annonce ce jour son chiffre d’affaires pour le 1er semestre 2022, clos le 30 juin 2022. En...
Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing
11 févr. 2021 08h00 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn. and DEERFIELD, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and...
Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus
16 nov. 2020 11h20 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
Aegis Sciences Corporation Announces National Launch of COVID-19 Antibody Testing Utilizing Convenient Dry Blood Spot Technology
31 août 2020 10h30 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
Aegis Sciences Corporation Testing for Coronavirus Disease 2019 (COVID-19) Now Authorized to Report in all 50 states
09 juin 2020 12h11 HE
|
Aegis Sciences Corporation
NASHVILLE, Tenn., June 09, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...